ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

BDX Becton Dickinson and Company

227.76
-1.08 (-0.47%)
After Hours
Last Updated: 22:23:03
Delayed by 15 minutes
Share Name Share Symbol Market Type
Becton Dickinson and Company NYSE:BDX NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  -1.08 -0.47% 227.76 228.68 225.97 228.68 613,308 22:23:03

BD to Announce Financial Results for its Third Quarter of Fiscal 2024

03/07/2024 1:30pm

PR Newswire (US)


Becton Dickinson (NYSE:BDX)
Historical Stock Chart


From Jun 2024 to Jul 2024

Click Here for more Becton Dickinson Charts.

FRANKLIN LAKES, N.J., July 3, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will report financial results for its third quarter of fiscal year 2024 on Thursday, August 1, 2024. A news release will be issued at approximately 6:30 a.m. Eastern Time (ET) and will be available at www.bd.com/investors, along with related presentation materials. The news release and presentation materials will include summary financial information for the company's third quarter of fiscal year 2024, which ended on June 30, 2024.

BD management will host an audio webcast at 8 a.m. ET on August 1, 2024 to discuss its financial results and provide an update on its operations and strategy. The audio webcast can be accessed at BD's investor relations website at www.bd.com/investors and a replay will be available shortly after the call at the same website.

About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X (formerly Twitter) @BDandCo or Instagram @becton_dickinson. 

Contacts:




Media:                                             

Investors:

Troy Kirkpatrick                                 

Adam Reiffe

VP, Public Relations                       

Sr. Director, Investor Relations

858.617.2361                                

201.847.6927       

troy.kirkpatrick@bd.com              

adam.reiffe@bd.com     

 

Cision View original content:https://www.prnewswire.com/news-releases/bd-to-announce-financial-results-for-its-third-quarter-of-fiscal-2024-302188455.html

SOURCE BD (Becton, Dickinson and Company)

Copyright 2024 PR Newswire

1 Year Becton Dickinson Chart

1 Year Becton Dickinson Chart

1 Month Becton Dickinson Chart

1 Month Becton Dickinson Chart